PlatinumRx Undisclosed stage: $32M

Nov 12, 2026Public sources — Collected from public sources, not yet cross-checked.

PlatinumRx raised $32 million in an undisclosed stage round led by Sofina Ventures, announced Nov. 12.

Facts

Company: PlatinumRx
Amount: $32 million
Currency: USD
Stage: Undisclosed stage
Announced: Nov 12, 2026
Valuation: $200 million (officially disclosed)

Investors

Led by: Sofina Ventures

Sources

1.Exclusive: Sofina To Lead PlatinumRx’s $32 Mn Funding At $200 Mn Valuation — Inc42, Nov 12, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Nov 12, 2026